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ABSTRACT
The Mus81–Eme1 complex is a structure-specific
endonuclease that preferentially cleaves nicked
Holliday junctions, 30-flap structures and aberrant
replication fork structures. Mus81
 /  mice have
been shown to exhibit spontaneous chromosomal
aberrations and, in one of two models, a predis-
position to cancers. The molecular mechanisms
underlyingitsroleinchromosomeintegrity,however,
are largely unknown. To clarify the role of Mus81 in
human cells, we deleted the gene in the human
colon cancer cell line HCT116 by gene targeting.
Here we demonstrate that Mus81 confers resistance
to DNA crosslinking agents and slight resistance to
otherDNA-damagingagents.Mus81deficiencyspon-
taneously promotes chromosome damage such as
breaks and activates the intra-S-phase checkpoint
through the ATM-Chk1/Chk2 pathways. Furthermore,
Mus81 deficiency activates the G2/M checkpoint
through the ATM-Chk2 pathway and promotes DNA
rereplication. Increased rereplication is reversed by
the ectopic expression of Cdk1. Haploinsufficiency of
Mus81orEme1alsocausessimilarphenotypes.These
findings suggest that a complex network of the
checkpoint pathways that respond to DNA double-
strand breaks may participate in some of the pheno-
types associated with Mus81 or Eme1 deficiency.
INTRODUCTION
Precise replication of the entire genome during the S phase of
the cell cycle is essential for cell survival. The progression of
replication forks can be stalled in response to exogenous and
endogenous sources, including depletion of deoxyribonuc-
leotide pools, inhibition of replication proteins and aberrant
DNA structures. Stalled replication forks can degenerate into
broken forks, leading to chromosomal rearrangements and
deletions (1). To avoid such deleterious events, all eukaryotes
have evolved cell cycle checkpoint machineryand DNA repair
pathways (2). The homologous recombination repair pathway
contributes to the accurate repair of DNA damage; however, to
promote cell survival, homologous recombination also parti-
cipates in chromosomal rearrangements when replication
forks are stalled (3).
Mus81 was originally identiﬁed as a member of the
XPF family of endonucleases that physically interacts with
Rad54 in Saccharomyces cerevisiae and Cds1 (Chk2) in
Schizosaccharomyces pombe (4,5). The gene confers resist-
ance to agents that lead to replication fork stalling or collapse,
including ultraviolet (UV) radiation, methylmethane sulfonate
(MMS), hydroxyurea and camptothecin, suggesting a role for
Mus81 in the rescue of stalled and collapsed replication forks
(6). In contrast, Mus81-deﬁcient murine cells are not hyper-
sensitive to camptothecin (7). The functional binding partner
of the protein is MMS4 in S.cerevisiae (8) and Eme1 in
S.pombe (9) and mammals (10–13). The synthetic lethality
of mus81 (or mms4) sgs1 (or top3) double mutants suggests
a functional link between Mus81 and Sgs1 helicases in the late
steps of recombination (4,8). In vitro, the Mus81–Eme1 com-
plex preferentially cleaves 30-ﬂap structures, various aberrant
replication fork structures, and nicked Holliday junctions, sug-
gesting that the complex plays a role in stalled replication fork
processing and DNA repair by homologous recombination
(14–16).
Loss of Mus81, MMS4 or Eme1 results in a reduction in
sporulation and spore viability in yeast (8,9,17). Poor spore
viability in mus81 or eme1 mutants of S.pombe is suppressed
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doi:10.1093/nar/gkj495by eliminating Rec6 or Rec12, proteins required for the forma-
tion of double-strand breaks (DSBs), which initiates meiotic
recombination. Expression of the bacterial Holliday junction
resolvase RusA has been found to rescue the mus81 meiotic
defect (9). Thus, Mus81, MMS4 and Eme1 have been implic-
ated in the processing of homologous recombination interme-
diates in yeast meiosis. The role of the Mus81–Eme1 complex
in mitotic homologous recombination in mammals, however,
remains uncertain (10,11,18). Remarkably, both Mus81
+/  and
Mus81
 /  mice exhibit a profound predisposition to lympho-
mas and other cancers (18), although a subsequent study found
no increased susceptibility to cancer in a different Mus81
 / 
model (7).
The role of Mus81 in genome integrity in response to
replication stress has been proposed to be related to its
physical association with Cds1 (Chk2) in ﬁssion yeast (19).
Cds1-dependent phosphorylation of Mus81 prevents it from
cleaving stalled replication forks that lead to replication fork
breakage and chromosomal rearrangements by dissociating it
from chromatin in cells exposed to hydroxyurea. Spontaneous
and mitomycin C (MMC)-induced DNA damage such as
breaks and triradial exchanges is increased in Mus81
+/  and
Mus81
 /  mouse cells. In addition to these aberrations, the
mutant cells have been shown to have an increased rate of
aneuploidy (18).
Despite accumulating evidence that Mus81 plays a role in
the processing of aberrant replication fork structures, the
molecular mechanisms underlying its role in chromosome
stability remain unclear. To clarify the role of Mus81–
Eme1 in human cells, we deleted the genes in the human
colon cancer cell line HCT116 by gene targeting. The advant-
ages of using this cell line are that it allows efﬁcient gene
targeting in the presence of an intact p53 gene (20) and the
cellular ploidy is stable. Here we show that Mus81 deﬁciency
activates the intra-S-phase and G2/M checkpoints and pro-
motes DNA rereplication. This promotion of DNA rereplica-
tion was reversed by the forced expression of Cdk1. These
ﬁndings provide new insight into the role of the Mus81–Eme1
complex in the control of human cell ploidy.
MATERIALS AND METHODS
Gene targeting at the Mus81 and Eme1 loci in HCT116
Targeting vectors were designed for in-frame insertion of
promoterless drug resistance genes in exon 3 of Mus81 or
in exon 2 of Eme1. A 2.5 kb 50-homology arm of Mus81
was ampliﬁed by PCR from the isogenic DNA of HCT116
cells using primers 50-GCCATGTCCAACGTCAGTA-30 and
50-ATCGATTCTCTCCAGATGGTGAGT-30. A 1.7 kb
30-homology arm of Mus81 was ampliﬁed using primers
50-ATCGATACTTGCGGAAGTCCA-30 and 50-AGGCAG-
AGGGGACAACACAG-30. A 2.6 kb 50-homology arm of
Eme1 was ampliﬁed using primers 50-TTCACAGCACTTGC-
CAGTCT-30 and 50-ATCGATAATCCAGTGAGGGTGAT-
GAC-30. A 1.8 kb 30-homology arm of Eme1 was ampliﬁed
using primers 50-ATCGATTGTGAAGCCTCCTGTCCT-30
and 50-GGAACTGTCCTGTGTTACTG-30. Both arms were
cloned into pCR2.1 (Invitrogen) by the TA cloning method.
The 30-arms of Mus81 and Eme1 were excised by digestion
with ClaI/SpeI and ClaI/XhoI, respectively, and subcloned
into the vectors containing the 50-arms. Neomycin and
blasticidin resistance cassettes were inserted into the ClaI
site of the vector containing both arms. Gene targeting in
HCT116 was performed as described previously (21).
Ectopic expression of the Mus81 and Eme1 cDNAs
The human Mus81 cDNA was ampliﬁed by PCR from cDNA
derived from normal human cells using primers 50-TGAT-
CTCAACGGTCCTGC-30 and 50-GGGCTGTTTCACGGC-
ATAA-30. The human Eme1 cDNA was ampliﬁed using
primers 50-AGTTGAAAGAGTGGCGGGA-30 and 50-CTCA-
TCCCTGAGGGCTAGAA-30. The cDNAs were inserted into
pCR2.1, and the sequences were conﬁrmed. The expression
vectors were designed to insert the genes under the control
of the MSV enhancer and the MMTV promoter. Transfected
cells were selected in the presence of 900 mg/ml Zeocin 
(Invitrogen).
Sensitivity to DNA-damaging agents
Sensitivity to MMC was measured as described previously
(22). To measure sensitivity to hydroxyurea, we plated the
cells at a density of 2 · 10
3 cells per 60 mm dish, treated
them with the agent for 6 h, and washed them three times
with phosphate-buffered saline (PBS). To measure the sens-
itivity to UV treatment, we plated the cells at the same density
and irradiated them. After 7 days of culturing, colonies were
counted.SensitivitytootherDNA-damagingagentswasmeas-
ured as described previously (21). When knockout or comple-
mented cells showed slow growth compared to wild-type cells,
colonies were further cultured for 2 to 3 days and counted.
Focus formation of Rad51 and Rad54
Radiation-induced focus formation of Rad51 and Rad54 was
performed as described previously (21). MMC-induced focus
formation was examined by treatment with 0.8 mg/ml MMC
for 1 h.
Cell cycle analysis
Cell synchronization by double-thymidine block was per-
formed as described previously (23). Flow cytometry was
performed with a FACSCalibur (Becton Dickinson) using
the CellQuest software package.
Kinase assay
Immunoprecipitation was performed in the presence of phos-
phatase inhibitors (5 mM cantharidin, 5 nM microcystin LR
and 25 mM bromotetramisole oxalate) essentially as described
(22). Immunoprecipitates were washed three times in lysis
buffer and three times in 25 mM HEPES (pH 7.4). The kinase
reaction was performed at 30 C for 20 min in a total of 40 ml
of reaction buffer [25 mM HEPES (pH 7.4), 15 mM MgCl2,
80 mM EGTA, 1 mM DTT, 0.1 mM ATP and 3 mCi
[g-
32P]ATP]. Histone H1 (10 mg) was used as a substrate for
the cyclin E, cyclin A and cyclin B kinase assays. Glutathione
S-transferase (GST)-Cdc25C (200–256) was used as a sub-
strate for the Chk2 kinase assay and was prepared as follows.
The Cdc25C (200–256) fragment was ampliﬁed by PCR from
cDNA derived from normal human cells using primers
50-GAAAGATCAAGAAGCAAAGGTGAGC-30 and 50-TA-
AGCCCTTCCTGAGCTT-30 and inserted into pGEX-5X-1
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transform Escherichia coli BL21, and expression of the
fusion protein was induced by adjusting the culture to 1 mM
Isopropyl-b-D-thiogalactopyranoside (IPTG). The fusion pro-
tein was puriﬁed using a glutathione–Sepharose 4B column
(Amersham Pharmacia). The kinase reaction products were
boiled in sample buffer and analyzed by SDS–PAGE.
Antibodies
Antibodies to Mus81 (N-20), cyclin A (C-19), cyclin E (C-19),
cyclin B1 (GNS1), Cdc2 (Cdk1) (17), Cdk2 (D-12), Chk2
(A-12), Chk1 (G-4), ATR (N-19) and actin (C-2) were from
Santa Cruz Biotechnology. Antibodies to phospho-Chk2
(Thr-68), phospho-Chk1 (Ser-317) and p21 (DCS60) were
from Cell Signaling Technology. The antibody to ATM
(NB100–104) was from Novus Biologicals.
Immunofluorescence
Cells were grown overnight on coverslips and ﬁxed for
10 min in 4% paraformaldehyde. Cells were blocked with
10% horse serum and incubated with primary antibodies
at room temperature for 1 h and with secondary antibodies
for 30 min. Finally, cells were counterstained with 40,60-
diamidino-2-phenylindole (DAPI) and mounted.
siRNA transfection
Eight hours prior to transfection, cells for the assay of ATM
and ATR expression were seeded in a 100 mm dish at 1 · 10
6
cells/dish. Cells for immunoﬂuorescence were seeded on
coverslips at 1 · 10
5 cells/coverslip. The siRNA sequences
for ATM used in the study were 50-CAUCUAGAUCGGC-
AUUCAGtt-30 and 50-UGGUGCUAUUUAACGGAGCUtt-30.
The siRNA sequence for ATR was 50-AACCUCCGUGAU-
GUUGCUUGAtt-30. These siRNAs were synthesized by
Sigma Genosys. A siCONTROL nontargeting siRNA from
Dharmacon was used as a negative control. Transfection
was performed using Lipofectamine 2000 transfection reagent
(Invitrogen) according to the manufacturer’s instructions.
For western blot analysis, the Lipofectamine–siRNA complex
was not removed during incubation. Cells were harvested at
48 h post-transfection. For immunoﬂuorescence after double-
thymidine block, the transfection mixture was removed after
the ﬁrst thymidine block.
Ectopic expression of Cdk1
The human Cdk1 cDNA was ampliﬁed by PCR from cDNA
derived from normal human cells using primers 50-GCTCTT-
GGAAATTGAGCGGA-30 and 50-AGAAGACGAAGTACA-
GCTGAAGT-30. The cDNAs were inserted into pCR2.1, and
the sequences were conﬁrmed. The Cdk1 expression vector
was designed to insert the gene under the control of the MSV
enhancer and the MMTV promoter. Cdk1-overexpressing
cells were selected in the presence of 900 mg/ml Zeocin 
(Invitrogen).
RESULTS
Generation of Mus81-deficient HCT116 cells
To investigate Mus81 function in human cells, we inactivated
its gene in HCT116 cells by gene targeting. Targeting vectors
were designed such that exon 3 was disrupted by promoterless
antibiotic-resistance genes (Figure 1A). We obtained two
independent Mus81
+/  clones from 744 neomycin-resistant
colonies and two Mus81
 /  clones from 2380 neomycin-
and blasticidin-resistant colonies derived from a single
Mus81
+/  clone (#653). Southern blot analysis using
both 50- and 30-probes conﬁrmed that both wild-type alleles
had been correctly inactivated by gene targeting in the
Mus81
 /  cells (Figure 1B). Northern blot analysis revealed
no expression of the gene in these clones (Figure 1C). Because
no additional bands were detected using the full-length Mus81
cDNA as a probe, it is unlikely that aberrant transcripts were
generated by the disruption of exon 3. The correct targeting
events were conﬁrmed by western blot analysis (Figure 1D).
Levels of expression comparable to or much higher than that
of endogenous expression were achieved in these mutants by
the introduction of the human Mus81 cDNA.
Generation of Eme1-deficient HCT116 cells
To compare the role of Mus81 in human cells with that of
Eme1, exon 2 of Eme1 was disrupted by a neomycin resistance
gene (Figure 1E). We obtained two independent Eme1
+/  cells
from 5250 neomycin-resistant colonies. Eme1
 /  cells were
not successfully generated because Eme1
+/  cells grow
slowly; however, Eme1
+/  cells were sufﬁcient for the purpose
ofcomparing therolesoftheseproteins.Southernandnorthern
blot analyses conﬁrmed the disruption of one allele of the gene
(Figure 1F and G). A level of expression comparable to that of
endogenous expression was achieved by the expression of
human Eme1 cDNA in Eme1
+/  cells.
Roles of the Mus81–Eme1 complex in the sensitivity
to DNA damage
We next examined the sensitivity of Mus81 or Eme1 mutant
cells to DNA damage by measuring their ability to form
colonies following exposure to DNA-damaging agents.
Because knockout cells and some complemented cells grew
slowly, we took the growth rate into account in the counting
of colonies (see Materials and Methods). Modest sensitivity
to MMC was observed in Mus81
+/  cells (1.5-fold) and
Mus81
 /  cells (4-fold) (Figure 2A). We noted a similar
mild sensitivity to cisplatin in Mus81
 /  cells. Mus81 deﬁ-
ciency resulted in a slight sensitivity to UV radiation, MMS,
hydroxyurea and ionizing radiation (Figure 2B–G). The
expression of Mus81 cDNA in Mus81
 /  cells restored the
sensitivities to DNA-damaging agents to the wild-type levels.
A slight increase in sensitivity to cisplatin, UV radiation and
hydroxyurea was observed in Mus81
+/  cells. A similar sens-
itivity to MMC and hydroxyurea was found in Eme1
+/  cells.
The expression of Eme1 only partially complemented the
sensitivity to MMC. This is probably explained by the level
of Eme1 expression in complemented cells: even if levels
comparable to the endogenous levels are achieved by con-
stitutive expression, they may not be sufﬁcient for full com-
plementation in response to DNA damage. Furthermore, the
level of Mus81 expression is strictly dependent on the cell
cycle (24), and the peak of Mus81 expression occurs in the S
and G2 phases. Like Mus81 expression, Eme1 expression may
vary according to the stage of the cell cycle. These results
indicate that Mus81 and Eme1 contribute to the resistance
882 Nucleic Acids Research, 2006, Vol. 34, No. 3Figure1.GenerationofHCT116celllinesdeficientinMus81orEme1bygenetargeting.(A)SchematicrepresentationoftheMus81locus,thetargetingvectors,and
thetargetedalleles.RelevantrestrictionsitesandthepositionoftheprobesusedforSouthernblotanalysisareshown.(B)Southernblotanalysisconfirmingtargeted
integration at the Mus81 locus. DNAs were digested with SacI or BamHI and hybridized with the probes depicted in (A). (C) Northern blot analysis confirming the
expression levels of Mus81. Poly(A)
+ RNAs were isolated and hybridized with the full-length Mus81 cDNA. Northern blotting for glyceraldehyde 3-phosphate
dehydrogenase(GAPDH)wasperformedtoconfirmequalloading.(D)WesternblotanalysisconfirmingtheproteinexpressionlevelsofMus81.Westernblottingfor
actinwasalso carriedoutto confirmequal loading.(E) Schematic representation ofthe Eme1locus,thetargetingvectorandthe targetedallele. Relevantrestriction
sitesandthepositionoftheprobesusedforSouthernblotanalysisareshown.(F)SouthernblotanalysisconfirmingtargetedintegrationattheEme1locus.DNAswere
digestedwithSphIandhybridizedwiththeprobesdepictedin(E).(G)NorthernblotanalysisconfirmingtheexpressionlevelsofEme1.Poly(A)
+RNAswereisolated
and hybridized with the full-length Eme1 cDNA.
Nucleic Acids Research, 2006, Vol. 34, No. 3 883Figure 2. Sensitivity to DNA-damaging agents. (A–F) Sensitivities to MMC, MMS, cisplatin, UV radiation, ionizing radiation and hydroxyurea. Values represent
the means ± the standard error of the mean for three independent experiments. Mus81
+/  (#653), Mus81
 /  (#150) and Eme1
+/  (#376) cells were used. (G) D37
values of sensitivity to DNA-damaging agents. Graph Pad Prism4 software was used to calculate the values.
884 Nucleic Acids Research, 2006, Vol. 34, No. 3of human cells to DNA-damaging agents such as DNA
crosslinking agents.
Rad51 plays a central role in the early stages of homo-
logous recombination and forms nuclear foci in a DNA
damage-dependent manner (25).Impaired Rad51 focus forma-
tion has been reported in chicken and mammalian cells with
defective homologous recombination (22,26,27). Rad54 plays
a role in homologous recombination by dissociating Rad51
from nucleoprotein ﬁlaments formed on double-stranded DNA
(28), and it forms nuclear foci that colocalize with foci of
Rad51 (29). To investigate the role of Mus81 in the Rad51-
dependent recombination pathway, we examined damage-
dependent focus formation of Rad51 and Rad54 by treating
cells with 0.8 mg/ml MMC or 8 Gy of ionizing radiation. We
found no difference in focus formation between wild-type and
Mus81
 /  cells (data not shown), suggesting that Mus81 is not
required for focus formation by these proteins.
Mus81–Eme1 is required for chromosome stability
A defect in homologous recombination repair leads to chro-
mosome instability (30). We examined chromosomal aberra-
tions in the presence of colcemid using metaphase spreads.
The frequency of abnormal cells harboring chromatid- and
chromosome-type aberrations such as gaps and breaks
(Figure 3) was 4.5% in wild-type cells, whereas it increased
to 10.4% in Mus81
+/  cells and 14.5% in Mus81
 /  cells
(Table 1). Expression of the Mus81 cDNA partially comple-
mented these phenotypes (6.7 and 5.7%, respectively). The
number of cells showing abnormalities was also increased in
Eme1
+/ cells(10.7%),anditwas reduced bythe expressionof
the Eme1 cDNA (7.4%).
In addition to these aberrations, the numbers of tetraploid
cells resulting from DNA rereplication (Figure 3) were signi-
ﬁcantly increased in the mutant cells (Table 1). The frequency
of tetraploidy in wild-type cells was 0.67%, whereas it
increased to 1.88% (Mus81
+/ ) and 2.46% (Mus81
 / )i n
the mutants. Differences in frequency were statistically signi-
ﬁcant between wild-type and Mus81
+/  cells (P < 1.0 · 10
 4)
and Mus81
 /  cells (P < 1.0 · 10
 6). The differences were
statistically evaluated using multiple logistic regression ana-
lysis taking Poisson errors into account. The expression of the
Mus81 cDNA in the mutants reduced the number of tetraploid
cells to a level that was comparable to wild-type cells. The
frequency of tetraploid cells was also increased to 2.16% in
Eme1
+/  cells (P < 1.0 · 10
 5), and this value was reduced to
1.20% by the expression of the Eme1 cDNA. Increases in
DNA content resulting from DNA rereplication were not
detected by FACS analysis, as only a small proportion of
cells underwent rereplication.
Figure 3. Chromosomal aberrations in Mus81
 /  (#150) cells. The arrow in the left panel indicates a chromosome break. The arrow in the middle panel indicates a
chromatid gap. Rereplication is shown in the right panel. In the left and middle panels, only a part of metaphase chromosome image is shown.
Table 1. Chromosomal aberrations
Cell line
a Chromatid-type
b (%) Chromosome-type
b (%) Abnormal cells
b (excluding tetraploidy) (%) Tetraploidy
c
Mus81
+/+ 2.5 ± 0.5 2.4 ± 1.1 4.5 ± 1.0 0.67% (23/3413)
Mus81
+/  4.9 ± 1.2 6.2 ± 1.1 10.4 ± 1.1 1.88% (39/2077)
Mus81
+/  + Mus81 3.2 ± 1.6 4.5 ± 1.5 6.7 ± 0.8 0.58% (6/1041)
Mus81
 /  7.0 ± 1.3 10.0 ± 2.0 14.5 ± 0.5 2.46% (37/1503)
Mus81
 /  + Mus81 2.4 ± 0.6 3.5 ± 1.5 5.7 ± 2.1 0.88% (27/3059)
Mus81
 /  + Cdk1(#1) 6.2 ± 3.0 9.4 ± 4.1 12.9 ± 1.9 0.50% (10/2000)
Mus81
 /  + Cdk1(#7) 4.0 ± 0.9 10.0 ± 0.5 11.2 ± 0.3 0.54% (6/1105)
Mus81
+/+ + Cdk1 2.5 ± 0.5 5.7 ± 1.6 6.9 ± 0.3 0.67% (2/300)
Eme1
+/  6.4 ± 1.6 6.5 ± 1.3 10.7 ± 0.3 2.16% (63/2919)
Eme1
+/  + Eme1 3.5 ± 0.9 5.2 ± 1.2 7.4 ± 1.3 1.20% (15/1248)
aMus81
+/  (#653), Mus81
 /  (#150) and Eme1
+/  (#376) cells were used.
bA total of 200 cells were scored for each line. Results represent the means ± SD of three independent experiments.
cThefrequencyoftetraploidyisshownasapercentageoftetraploidcellstothetotalnumberofmetaphasecellsanalyzed;absolutenumbersaregiveninparentheses.
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The growth rates of Mus81
+/ , Mus81
 /  and Eme1
+/  cells
were signiﬁcantly lower than that of wild-type cells
(Figure 4A). The doubling time of wild-type cells was 17 h,
whereas the times for Mus81
+/ , Mus81
 /  and Eme1
+/  cells
were 21, 22 and 21.5 h, respectively. Expression of the
Mus81 or Eme1 cDNA partially complemented this pheno-
type. To examine the proﬁles of cell cycle progression,
we performed FACS analysis using cells synchronized by
double-thymidine block. We observed a small difference in
the kinetics of accumulation of cells in the S and G2/M phases
between wild-type and Mus81
 /  cells (Figure 4B). There was
a peak in G2/M phase accumulation 6 h after release in wild-
type cells, whereas G2/M phase accumulation was found 6
and 8 h after release in Mus81
 /  cells.
Mus81 or Eme1 deficiency activates the
intra-S-phase checkpoint
Cell cycle progression through S phase is regulated by cyclin
E/Cdk2 and cyclin A/Cdk2. We therefore investigated the
effects of Mus81 deﬁciency on the S phase progression by
performing cyclin E and cyclin A kinase assays using lysates
from cells synchronized in the G1/S phase (Figure 5A). The
cyclin E and cyclin A kinase activities were apparently lower
in Mus81
 /  cells than in wild-type cells at 0 and 0–8 h after
release, respectively. Quantitative analysis revealed that
Mus81
 / cellshada 40%reduction incyclinEkinaseactivity
at 0 h and a 50% reduction in cyclin A kinase activity at 4 h
compared to wild-type cells. The levels of cyclin E and cyclin
Ai nMus81
 /  cells were almost the same as inwild-type cells
at this stage of the cell cycle, indicating that S phase check-
point activation was responsible for the reductions in cyclin
kinase activities.
Because the mutant cells showed a spontaneous delay of
cell cycle progression during the S phase, we ﬁrst investigated
the effect of Mus81 deﬁciency on the ATR-Chk1 pathway,
which regulates the basal turnover of Cdc25A (31). Western
blot analysis using an anti-phospho-Chk1 antibody (Ser-317)
revealed that levels of phospho-Chk1 were high in the early
S phase and that the levels in Mus81
 /  cells were the same as
in wild-type cells (Figure 5B). This ﬁnding is consistent
with the proposed role of Chk1 activation in the maintenance
of the physiological turnover of Cdc25A.
However, the involvement of Chk1 in a DNA damage-
dependent checkpoint cannot be evaluated by this method
because the basal levels of phospho-Chk1 were high during
the S phase. We therefore examined the damage-dependent
Chk1 activation at the single-cell level by immunoﬂuores-
cence using the same antibody (Figure 5C). Clear staining
in the nucleus indicating the damage-dependent phosphoryla-
tion of Chk1 on Ser-317 was observed in a small proportion of
cells. This staining pattern was found in 0.3 ± 0.1%
(mean ± SD) of wild-type cells and in 1.9 ± 0.1% of
Mus81
 /  cells (n ¼ 500). The frequencies of the staining
ranged from 0.9 ± 0.1% to 1.5 ± 0.2% in Mus81
+/  and
Eme1
+/  cells.
Toinvestigate whether ATM orATR regulates Chk1 activa-
tion by phosphorylation in the S phase, ATM and ATR were
knocked down by siRNA (Figure 5D). Silencing of ATM
reduced the frequency to 0.5 ± 0.3% in Mus81
 /  cells,
whereas silencing of ATR or transfection of control siRNA
did not affect the frequency, indicating that the ATM-Chk1
pathway was activated in the S phase in Mus81
 /  cells
(Figure 5C). This pathway has been shown to be activated
in response to DSBs induced by ionizing radiation (32).
The intra-S-phase checkpoint in response to DSBs was
ﬁrst shown to be mediated by the ATM-Chk2-Cdc25A-
Cdk2 pathway (33). Next, we investigated Chk2 activation
in the S phase by immunoﬂuorescence using an anti-
phospho-Chk2 (Thr-68) antibody (Figure 5E). Phosphoryla-
tion of Chk2 on Thr-68 is required for the initiation of
Chk2 activity. Clear staining of phospho-Chk2 in the nucleus
was not observed in wild-type cells, but it was observed in
2.3 ± 0.3%ofMus81
 / cells (n ¼ 500).Thefrequencyofthe
staining ranged from 1.0 ± 0.2% to 1.6 ± 0.2% in Mus81
+/ 
and Eme1
+/  cells, respectively. Silencing of ATM reduced
the frequency to 0.7 ± 0.5%, whereas silencing of ATR or
transfection of control siRNA did not affect the frequency,
indicating that ATM acted as an upstream kinase for Chk2
activation. Thus, both the ATM-Chk1 and ATM-Chk2 check-
pointpathways were activated during the Sphase inthe Mus81
and Eme1 mutant cells.
Figure 4. Effects of Mus81 or Eme1 deficiency on cell cycle progression.
Mus81
+/  (#653), Mus81
 /  (#150) and Eme1
+/  (#376) were examined.
(A) Growth curves. The results show the means ± the standard error of the
mean for three independent experiments. (B) Cell cycle distribution. The cells
were synchronized in G1/S by double-thymidine block and released. Samples
were taken at the indicated time points and subjected to FACS analysis.
886 Nucleic Acids Research, 2006, Vol. 34, No. 3Figure 5. Activation of the intra-S-phase checkpoint. (A) Cyclin E and cyclin A kinase activities with histone H1 as the substrate. Wild-type and Mus81
 /  (#150)
cells were synchronized in G1/S by double-thymidine block and released. (B) Western blot analysis of synchronized wild-type and Mus81
 /  (#150) cell extracts
using anti-phospho-Chk1 (Ser-317). The experiments in (A) and (B) were performed three times, and representative results are shown. (C) Immunofluorescence of
Mus81
 / cellssynchronizedinSphaseusinganti-phospho-Chk1(Ser-317).Thefrequenciesofpositivestainingforphospho-Chk1areshownintherightpanel.(D)
Western blot analysis of unsynchronized Mus81
 /  (#150) cells transfected with siRNAs. The experiment was performed three times. (E) Immunofluorescence of
Mus81
 / cellssynchronizedinSphaseusinganti-phospho-Chk2(Thr-68).Thefrequenciesofthepositivestainingofphospho-Chk2areshownintherightpanel.In
(C)and(E),cells werefixed2 hafterrelease,anda total of500cells wereexaminedforeach cell line.Theresultsrepresentthe means ± standarddeviationofthree
independent experiments. IB, immunoblot; IP, immunoprecipitation; p-Chk, phospho-Chk; WT, wild-type.
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G2/M checkpoint
Because FACS proﬁles revealed a difference in the accumu-
lation of cells in G2/M, we investigated the effects of Mus81
deﬁciency on the G2/M delay by running a cyclin B kinase
assay using cells synchronized in the G1/S phase (Figure 6A).
Cyclin B kinase activity was increased 6 h after release in
wild-type cells, whereas an increase in the kinase activity was
not obvious at 6 h but was clear at 8 h after release in the
mutant. Repeated experiments demonstrated that such a
difference between the wild-type and mutant cells could be
observedeither6or8hafterrelease,consistentwiththeresults
fromtheFACSanalysis.Therewere noapparentdifferencesin
cyclin B and Cdk1 levels between wild-type and Mus81
 / 
cells, excluding the possibility that reduced cyclin B kinase
activity was due to repression of these proteins. In addition, we
noticed that the level of cyclin B expression was high even in
the G1 phase at 10 h in the HCT116 cell line. This aberrant
expression of cyclin B has been observed in some human
cancer cells, suggesting that it may be associated with abnor-
mal proliferation of cancer cells (34). The high level of cyclin
B may account for the sustained cyclin B kinase activity
during the early G1 phase in wild-type cells.
Activation of Cdk1 by association with cyclin B is essential
for the initiation of the M phase. The delay of cyclin B activity
in Mus81
 /  cells may simply indicate that the cell cycle
progression was delayed by the preceding S phase delay.
Alternatively, G2/M checkpoint activation may be involved
in the delay of cyclin B activity. Chk1 and Chk2 play a role in
the G2/M checkpoint as effector kinases (35). To investigate
whether the G2/M checkpoint was activated in the mutants, we
therefore examined Chk1 and Chk2 kinase activities using a
recombinant GST-Cdc25C (200–256) fusion protein as a sub-
strate. These kinases preferentially phosphorylate Cdc25C on
Ser-216 (36). We examined the difference in Chk2 kinase
activity in synchronized cells. Chk2 kinase activity was
signiﬁcantly increased in the Mus81 mutant 6 h after release,
whereas an increase was not evident in wild-type cells
(Figure 6B). There were no differences in the levels of
Chk2. A more than 3-fold increase in Chk2 activity was
also observed in two Mus81
+/  cell lines as well as in two
Eme1
+/  cell lines, excluding the possibility that activation
of Chk2 was due to a clonal variation (Figure 6C). Expression
of Mus81 or Eme1 cDNA reduced this increase in Chk2
activity in the mutant cells (Figure 6C). Chk2 kinase phos-
phorylation of Cdc25C was not clearly observed before 6 h,
indicating that the increase in this activity at 6 h reﬂected the
G2/M checkpoint activation rather than a delay of the cell
cycle progression. The S phase checkpoint was activated in
Mus81
 /  cells from 0 to 4 h after release.
The increase in Chk2 kinase activity was abolished in the
presence of 0.5 mM caffeine (Figure 6C). Treatment with
0.5 mM caffeine for 1 h has little effect on DNA synthesis
(37), excluding the possibility that the elimination of Chk2
activity by caffeine was due to the delay in cell cycle progres-
sion. Because caffeine inhibits ATM and ATR kinase activ-
ities (38–40), they are likely required for this increase in Chk2
kinase activity. For this reason, we further investigated the
effect of siRNA silencing of ATM and ATR on Chk2 activity
(Figures 5D and 6D). Chk2 activity was reduced by silencing
of ATM but not by silencing of ATR, indicating that the acti-
vation of ATM in response to DNA damage is responsible for
the increase in Chk2 activity in Mus81
 /  cells. In contrast,
there was no clear difference in the phosphorylation of GST-
Cdc25C (200–256) by Chk1 in wild-type and Mus81
 /  cells
(Figure 6E). There was also no difference in p21 expression in
wild-type and Mus81
 /  cells (Figure 6F).
It is assumed that the p21-dependent G2/M checkpoint leads
to sustained cell cycle arrest, whereas the Cdc25-dependent
checkpoint leads to transient delay (41). Consistent with this
idea, many delayed cells eventually proceeded into the M
and G1 phases. These results show that, in addition to the
intra-S-phase checkpoint, the G2/M checkpoint was activated
in the Mus81 mutant cells via the ATM-Chk2 pathway.
Overexpression of Cdk1 prevents rereplication
Because deletion of Cdk1 promotes DNA rereplication in
human cells (42), reduced cyclin B kinase activity is likely
to cause increased rereplication in Mus81 mutants. We
examined this possibility by overexpressing Cdk1 in the
Mus81 mutants. Cdk1 kinase activity is regulated by accumu-
lation of Cdk1-associated cyclin B and removal of inhibitory
protein phosphorylations. Western blot analysis revealed
that levels of cyclin B were high in G2/M in Mus81
 / 
cells while the levels of Cdk1 were constant, suggesting
that overexpressed Cdk1 may be associated with endogenous
cyclin B. Given that overexpressed Cdk1 is not phos-
phorylated on inhibitory phosphorylation sites by overcoming
Wee1 and Myt1 kinase activities, Cdk1 activity is expected
to be increased. Because we showed that p21 is not induced
in Mus81
 / , it is not necessary to consider direct inhibition
of Cdk2 activity by p21. Consistent with this hypothesis, the
reduction of cyclin B kinase activity was reversed by the
overexpression of Cdk1 (Figure 6G). The increase in
cyclin B activity by ectopic expression of Cdk1 reduced the
frequency of tetraploidy from 2.46 to 0.50% and 0.54% in the
two Mus81
 /  cell lines (P < 1.0 · 10
 2) (Table 1). Thus,
the increased rereplication in Mus81 mutants was reversed
by ectopic expression of Cdk1.
DISCUSSION
In the current studies, we demonstrated that Mus81–Eme1
deﬁciency activates the intra-S-phase and G2/M checkpoints
in response to DNA damage and promotes DNA rereplication.
In addition, we conﬁrmed that the Mus81–Eme1 complex
contributes to the resistance against DNA-damaging agents
in human cells. These assays show quite small differences,
suggesting that there may be functional redundancy between
the Mus81–Eme1 complex and other repair proteins in the
response to DNA damage. Consistent with extensive genetic
studies in yeast, the results of the present study indicate that
there is no functional difference between Mus81 and Eme1 in
human cells.
Identiﬁcation of the physiological substrates of the
Mus81–Eme1 complex has long remained elusive. However,
a study showing the presence of resolvase activities in two
separate fractions from human cell extracts has signiﬁcantly
enhanced our understanding of this complex system (43,44).
The Mus81–Eme1 complex shows a greater activity for the
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Rad51C complex shows speciﬁc activity for Holliday junc-
tions. These ﬁndings suggest that replication forks or 30-ﬂaps
may be the in vivo substrates of the Mus81 endonuclease. The
present ﬁnding that the Mus81–Eme1 complex confers resist-
ance to DNA crosslinking agents, MMS and hydroxyurea
supports this idea because these agents cause stalled replica-
tion forks. However, it is also possible that recombination
intermediates such as D-loops and Holliday junctions are
the in vivo substrates of the endonuclease. This possibility
is supported by the observation that mutations in genes
such as RAD51, RAD52, RAD55 and RAD57 that play early
roles in recombination suppress the synthetic lethality of
mus81 (or mms4) sgs1 (or top3) mutants (45,46). If Mus81-
Mms4 directly cleaves replication forks and does not play a
late role, syntheticlethalitywould not berescuedby a defect in
these genes. The physical interaction of Mus81 with Rad54 in
yeast is consistent with this idea (5). Furthermore, Mus81 has
been shown to play a key role in the Rhp51-independent
recombination repair pathway in ﬁssion yeast by resolving
D-loops formed by Rad22 (47).
We observed spontaneous activation of the intra-S-phase
checkpoint through two independent cascades in Mus81
 / 
cells. The ATM-Chk2-Cdc25A-Cdk2 pathway has been
shown to play a role in the intra-S-phase checkpoint in
response to DSBs. In addition, the damage-dependent Chk1
pathway was activated by ATM but not by ATR. This ﬁnding
strongly suggests that the Mus81–Eme1 complex is involved
in the processing of DSBs. This notion is also supported by the
present ﬁnding that Mus81 or Eme1 deﬁciency led to the
activation of the G2/M checkpoint through the ATM-Chk2
pathway. DSBs that escape the intra-S-phase checkpoint
and/or DSBs generated in G2 can activate the G2/M check-
point. Thus, the recombination intermediates are likely to be
the in vivo target of the Mus81–Eme1 complex. It is also
possible that stalled replication forks, if unprocessed, generate
DSBs, which could activate the ATM-dependent checkpoint
pathway. In contrast to ATM, ATR kinase activity is activated
by several kinds of DNA damage, including those caused by
UV radiation and chemicals that make bulky base lesions, as
well as by stalled replication forks (48). Although the present
study demonstrated that Chk1 is not activated by ATR, it is
very likely that ATR was activated in Mus81
 /  cells. Despite
the fact that cyclin A activity was strongly repressed, activa-
tion of Chk1 and Chk2 could account for the S phase delay
only in a small proportion of the Mus81 and Eme1 mutant
cells. In addition to the intra-S-phase checkpoint, the replica-
tion checkpoint initiated by ATR is likely to play a major role
in the S phase delay resulting from Mus81 or Eme1 deﬁciency.
Identiﬁcation of the effectors that protect the replication fork
will address this issue.
Mus81 has been shown to be physically associated with
Cds1 (Chk2) in yeast and in human cells, suggesting a func-
tional link between these proteins. We found that ionizing
radiation- or MMC-induced phosphorylation of Chk2 on
Thr-68 is not affected by a deﬁciency of Mus81 (data not
shown), suggesting that Mus81 does not directly regulate
the function of Chk2. Conversely, phosphorylation of
Mus81 by Chk2 has been shown to be required for the main-
tenance of genome integrity during replication stress (19).
Evidence for the molecular mechanisms underlying check-
point activation in response to DNA damage has largely come
from studies in cells exposed to DNA-damaging agents. In
contrast to these studies, our results provide new insight into
the mechanism of checkpoint activation in response to DNA
damage that spontaneously arises from a defect in a single
processofDNArepairwherethereisnoexogenousDNAdam-
age.Reactivecellularmetabolitesareassumedtobecomeendo-
genousgenotoxicinsults.Becausethecellsweremoresensitive
toDNAcrosslinkingagentsthanotheragents,itisofinterestto
identifythesourcesofendogenousDNAinterstrandcrosslinks.
In addition to increased chromosomal aberrations such
as gaps and breaks, we found increased frequencies of
tetraploidy in the Mus81–Eme1 mutants. In yeast, B-type
cyclin-dependent kinases prevent rereplication by several
overlapping mechanisms, including phosphorylation of
ORC, down-regulation of Cdc6 and nuclear exclusion of
MCM proteins (49). The ability of these kinases to prevent
rereplication is also supported by the ﬁnding that cyclin B/
Cdk1 is associated with replication origins (50). In human
cells, deletion of Cdk1 by gene targeting results in increased
levels of tetraploidy (42). It is therefore likely that reduced
cyclin B/Cdk1 kinase activity caused increased rereplication
in the Mus81 mutants. This model is supported by our ﬁnding
that the overexpression of Cdk1 prevents rereplication in
Mus81 mutants, although we cannot exclude the possibility
that Cdk1 overexpression plays an indirect role in prevent-
ing rereplication. Chromosomes in tetraploid cells are very
unstable, as demonstrated by the ﬁnding that tetraploid-
derived mouse tumors have numerical and structural chromo-
somal aberrations (51). The aneuploidy observed in mouse
Mus81
 /  cells may result from chromosome instability in
tetraploid cells. Recent evidence has suggested that aneuploid
cells proceed through a tetraploid state (52). This possibility
may also account for the absence of a clear peak of 8C DNA
content in Mus81
 /  cells in FACS proﬁles. We observed
extremely low frequency of DNA contents ranging from 4C
to 8C at high magniﬁcation, which apparently concealed a
small peak at 8C.
Haploinsufﬁciency of Mus81 was found to cause pheno-
types similar to those of a complete loss of the gene. Similar
results were observed for Mus81
+/  and Mus81
 /  mice. Loss
Figure 6. ActivationoftheG2/Mcheckpoint.(A)CyclinBkinaseactivitywithhistoneH1asthesubstrate.Wild-typeandMus81
 / (#150)cellsweresynchronized
inG1/Sbydouble-thymidineblockandreleased.(B)Chk2kinaseactivityusingGST-Cdc25C(200–256)asthesubstrateandwhole-cellextractsfromwild-typeand
Mus81
 /  (#150) cells synchronized in G1/S and released. The experiments in (A) and (B) were performed five times. (C) Chk2 kinase activity on GST-Cdc25C
(200–256)ofsynchronizedcellsharvested6hafterrelease.Forcaffeinetreatment,cellswereincubatedinthepresenceof0.5mMcaffeinefor1hpriortocelllysis.
(D) The effects of ATM and ATR on Chk2 activity. Shown is the Chk2 kinase activity using GST-Cdc25C (200–256) as a substrate in extracts of Mus81
 /  (#150)
cells harvested 48 h after transfection with siRNA. (E) Chk1 kinase activity using GST-Cdc25C (200–256) as a substrate in extracts from wild-type and Mus81
 / 
(#150)cells synchronizedinG1/Sandreleased.CellstreatedwithUV radiationare usedaspositivecontrols.Thetreatedcellswereharvested5hafter UVradiation
(40J/m
2).Theexperimentsin(C),(D)and(E)wereperformedtwice,andrepresentativeresultsareshown.(F)Westernblotanalysisofextractsfromunsynchronized
cells usingan anti-p21antibody.(G) CyclinB kinaseactivitywithhistone H1 asa substratein extracts from unsynchronized cells.In(F) and (G), Mus81
 / (#150)
cells were used.
890 Nucleic Acids Research, 2006, Vol. 34, No. 3of heterozygosity is commonly observed in tumors. The
human Mus81 gene maps to chromosome 11q13.1. Although
loss of heterozygosity at the Mus81 locus in tumors has not
been reported, normal or precancerous cells have a chance to
lose one allele of Mus81. Given that cells lose one copy of
Mus81 during tumor progression, aberrant replication fork
structures and recombination intermediates are expected to
accumulate and eventually lead to further genomic instability.
Haploinsufﬁciency ofMus81may contribute totumorprogres-
sion through this mechanism. It is noteworthy that predisposi-
tion to cancer was not observed over 15 months in another
Mus81
 /  mouse model (7). This discrepancy may be
explained by a difference in strains. However, it is most likely
that Mus81 deﬁciency does not directly contribute to tumor
formation but rather induces chromosome aberrations such as
aneuploidy that do not directly lead to cancer. A long latency,
during which chromosomal aberrations accumulate, may be
required for tumor formation in such a situation. It is also
possible that additional modiﬁers that promote different
types of genomic instability are required for tumor formation.
The present ﬁnding that small changes in the gene dosage
of Mus81–Eme1 promote rereplication implicates the signi-
ﬁcance of small amounts of genotoxic insults in chromosome
stability. Even in the absence of exogenous genotoxic sources,
endogenous insults can lead to chromosome instability by
damaging DNA. Aberrant fork structures and recombination
intermediates are expected to accumulate in cells exposed to
genotoxic insults. These cells suffer from increased rereplica-
tion in response to DNA damage, which does not immediately
lead to tumor-associated genomic aberrations. Instead, this
pathway can contribute to tumor development by inducing
centrosome dysfunction and aneuploidy after numerous
rounds of the cell cycle. This scenario may explain cases of
radiation-induced carcinogenesis in which patients develop
tumors after long periods of exposure to low-dose radiation.
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